The week in health tech, explained in plain English.Get the free newsletter →
October 24, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Government

NIAID Names John Powers III as Acting Director

By Healthcare Technology News ·

The National Institutes of Health has appointed researcher John Powers III to lead the National Institute of Allergy and Infectious Diseases on an acting basis, according to STAT News. The move ends weeks of questions over who would run the institute, which had been operating without clear leadership.

Powers replaces Jeffery Taubenberger, who had been serving as acting director. NIAID is one of the most prominent institutes within the NIH, funding a large share of federal research on infectious diseases, immunology, and vaccines. The institute was previously led for decades by Anthony Fauci, who retired in 2022.

The appointment matters because NIAID's direction shapes national priorities on pandemic preparedness, vaccine development, and emerging threats. A prolonged leadership vacuum can slow grant decisions and strategic planning. Naming an acting director restores a clear chain of command, though the "acting" label signals that a permanent appointment and longer-term direction remain unsettled.

Sources

More in Government

Government

FDA Approves First Once-Weekly Insulin for Children

The FDA approved Novo Nordisk's Awiqli, the first once-weekly basal insulin for children 10 and older with Type 2 diabetes.

Why it matters: Weekly rather than daily insulin could improve adherence for a growing number of children with Type 2 diabetes.

Government

Feds Launch False Claims Act Self-Disclosure Pilot

HHS and the DOJ Civil Division have launched a six-month pilot letting healthcare companies self-report potential civil False Claims Act violations and settle through a coordinated civil release.

Why it matters: The pilot reshapes how hospitals and healthcare firms weigh self-reporting against federal fraud enforcement, with real consequences for compliance strategy.

Government

GOP Pushes Fraud Message to Deflect Healthcare Cost Anger

Republicans are elevating healthcare fraud as a midterm message to deflect voter anger over costs, while Democrats say the push targets blue states to justify Medicaid and ACA cuts.

Why it matters: Fraud-focused enforcement could reshape Medicaid and ACA funding, audits, and eligibility for the tens of millions who depend on those programs.